These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22263855)

  • 41. Association between the MMPI-2 restructured form (MMPI-2-RF) and malingered neurocognitive dysfunction among non-head injury disability claimants.
    Tarescavage AM; Wygant DB; Gervais RO; Ben-Porath YS
    Clin Neuropsychol; 2013; 27(2):313-35. PubMed ID: 23181937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Warrington Recognition Memory Test for words as a measure of response bias: total score and response time cutoffs developed on "real world" credible and noncredible subjects.
    Kim MS; Boone KB; Victor T; Marion SD; Amano S; Cottingham ME; Ziegler EA; Zeller MA
    Arch Clin Neuropsychol; 2010 Feb; 25(1):60-70. PubMed ID: 19906738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of overreported psychopathology with the MMPI-2-RF [corrected] validity scales.
    Sellbom M; Bagby RM
    Psychol Assess; 2010 Dec; 22(4):757-67. PubMed ID: 21133544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Victoria Symptom Validity Test: efficiency for detecting feigned memory impairment and relationship to neuropsychological tests and MMPI-2 validity scales.
    Slick DJ; Hopp G; Strauss E; Spellacy FJ
    J Clin Exp Neuropsychol; 1996 Dec; 18(6):911-22. PubMed ID: 9157115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The MMPI-2 Symptom Validity Scale (FBS) not influenced by medical impairment: a large sleep center investigation.
    Greiffenstein MF
    Assessment; 2010 Jun; 17(2):269-77. PubMed ID: 20124428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the MMPI-2-RF for Detecting Over-reported Symptoms in a Civil Forensic and Disability Setting.
    Nguyen CT; Green D; Barr WB
    Clin Neuropsychol; 2015; 29(2):255-71. PubMed ID: 25905684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Victoria Symptom Validity Test performance in children and adolescents with neurological disorders.
    Brooks BL
    Arch Clin Neuropsychol; 2012 Dec; 27(8):858-68. PubMed ID: 23037621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Let's not get hysterical: comparing the MMPI-2 validity, clinical, and RC scales in TBI litigants tested for effort.
    Thomas ML; Youngjohn JR
    Clin Neuropsychol; 2009 Aug; 23(6):1067-84. PubMed ID: 19343593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Test of Memory Malingering (TOMM): normative data from cognitively intact, cognitively impaired, and elderly patients with dementia.
    Teichner G; Wagner MT
    Arch Clin Neuropsychol; 2004 Apr; 19(3):455-64. PubMed ID: 15033228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detecting simulated memory impairment: further validation of the Word Completion Memory Test (WCMT).
    Hilsabeck RC; Gouvier WD
    Arch Clin Neuropsychol; 2005 Dec; 20(8):1025-41. PubMed ID: 16099137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The utility of the post-concussive symptom questionnaire.
    Van Dyke SA; Axelrod BN; Schutte C
    Arch Clin Neuropsychol; 2010 Nov; 25(7):634-9. PubMed ID: 20710017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Visual Association Test-Extended: a cross-sectional study of the performance validity measures.
    Meyer SR; de Jonghe JF; Schmand B; Ponds RW
    Clin Neuropsychol; 2017 May; 31(4):798-813. PubMed ID: 28156190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of cognitive and psychiatric impairment of psychotic disorders on the test of memory malingering (TOMM).
    Duncan A
    Assessment; 2005 Jun; 12(2):123-9. PubMed ID: 15914714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The incremental validity and clinical utility of the MMPI-2 infrequency posttraumatic stress disorder scale.
    Marshall MB; Bagby RM
    Assessment; 2006 Dec; 13(4):417-29. PubMed ID: 17050912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of the Malingering Discriminant Function Index for the MMPI-2.
    Bacchiochi JR; Bagby RM
    J Pers Assess; 2006 Aug; 87(1):51-61. PubMed ID: 16856786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Derivation and clinical validation of consistency indices on the test of memory malingering.
    Davis JJ; Wall JR; Whitney KA
    Arch Clin Neuropsychol; 2012 Nov; 27(7):706-15. PubMed ID: 22951670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of somatoform symptomatology on credibility of cognitive performance.
    Boone KB; Lu PH
    Clin Neuropsychol; 1999 Nov; 13(4):414-9. PubMed ID: 10806453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative analysis of MMPI-2 malingering detection models among inmates.
    Steffan JS; Morgan RD; Lee J; Sellbom M
    Assessment; 2010 Jun; 17(2):185-96. PubMed ID: 20124427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The validity and clinical utility of the MMPI-2 Malingering Depression scale.
    Bagby RM; Marshall MB; Bacchiochi JR
    J Pers Assess; 2005 Dec; 85(3):304-11. PubMed ID: 16318569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.